Non-vitamin K antagonist oral anticoagulants (NOACs) have changed the landscape for
stroke prevention in atrial fibrillation (AF). Given the huge burden of AF in Asians, more …

Atrial fibrillation (AF) is the most common arrhythmia conferring a fivefold increased risk of
stroke. Stroke prevention is the cornerstone of management of patients with AF. Asians have …

Atrial fibrillation (AF) is the most common sustained arrhythmia, causing a 2-fold increase in
mortality and a 5-fold increase in stroke. The Asian population is rapidly aging, and in 2050 …

Atrial fibrillation (AF) is the most common sustained arrhythmia. Both the incidence and
prevalence of AF are increasing, and the burden of AF is becoming huge. Many innovative …

Objectives To assess cost-effectiveness of direct oral anticoagulants (DOACs) compared
with vitamin K antagonists (VKAs) for stroke prevention in atrial fibrillation (AF) by pooling …

Background Atrial fibrillation (AF) is a severe epidemiological and public health concern
among the elderly population worldwide, with substantial economic and social burdens …

Background and Purpose The quality of anticoagulation is critical for ensuring the benefit of
warfarin, but this has been less well studied in Korean ischemic stroke patients with atrial …

Background Non-vitamin K oral antagonist anticoagulants (NOACs) have been widely used
in stroke prevention in atrial fibrillation (SPAF). The aim of this study was to compare the …

Dabigatran, a direct thrombin inhibitor, has robust data for the treatment of deep venous
thrombosis and pulmonary embolism, stroke prevention in non-valvular atrial fibrillation, and …

The introduction of non-vitamin K antagonist oral anticoagulants (NOACs) into clinical
practice represented a major change in the treatment of non-valvular atrial fibrillation …